GlassScriptPhysician profile
Lauren K Hackett
NPI 1922398320
$1,224.35
in general payments reported to CMS, 2019-2025
21 companies · $486 in 2025
The $486 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.51 · 2022: $236 · 2023: $313 · 2024: $93.00 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $156.84 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $147.81 | 2023-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Glaxosmithkline, LLC. | $130.46 | 2019-2025 | Arexvy, Shingrix, Penmenvy |
| Abbvie INC. | $106.13 | 2023-2024 | |
| Sanofi Pasteur INC. | $94.06 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $77.73 | 2022-2025 | |
| Alk-Abello, INC | $73.17 | 2025 | Neffy |
| Idorsia Pharmaceuticals US INC | $53.98 | 2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $49.80 | 2022 | |
| Dexcom, INC. | $45.15 | 2023-2025 | Dexcom G6 Transmitter |
| Kaleo, INC. | $41.52 | 2019-2022 | |
| Seqirus USA INC | $36.63 | 2022 | |
| Amgen INC. | $32.43 | 2023 | Tezspire |
| Mayne Pharma Commercial LLC | $26.83 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $24.65 | 2025 | Lumryz |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $23.92 | 2023 | Evusheld |
| Hologic Sales and Service, LLC | $22.59 | 2022 | |
| Livanova USA, INC. | $21.09 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Xeris Pharmaceuticals, INC. | $20.55 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.67 | 2023 | Xarelto |
| Abbott Laboratories | $19.34 | 2025 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Hackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.